A pharmaceutical company is developing an “off-switch” drug for an LSD trip, in the case that a bad trip can happen. Some would say there is no such thing.
Research investigating the antidepressant potential of psychedelics has blossomed in recent years. While traditional pharmacotherapy for depression poses adverse side effects and requires repeated dosing, psychedelic therapy produces persistent relief and lasting personality changes, even after as little as one or two treatment sessions. However, there’s debate within the field as to whether the antidepressant […]